Anti-Dengue Envelope antibody [D1-11(3)]
Be the first to review this product! Submit a review
|
(11 Publications)
Mouse Monoclonal POLG antibody. Suitable for I-ELISA, ELISA, Dot, WB and reacts with Dengue virus 1, Dengue virus 2, Dengue virus 3 samples. Cited in 11 publications.
View Alternative Names
Genome polyprotein, Genome polyprotein, pol, Capsid Protein, Dengue hemorrhagic fever, DENV-3
- I-ELISA
Supplier Data
Indirect ELISA - Anti-Dengue Envelope antibody [D1-11(3)] (AB9202)
Indirect ELISA Purified Mouse anti-Dengue Envelope (Clone #D1-11) (ab9202). Antigen- 500 ng/well. Incubated 60 minutes. Primary Antibody. Incubated 60 minutes. Secondary, HRP Goat-Anti Mouse IgG2a. Developed with TMB (10 minutes). Microplate reader set at 450nm.
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dengue Virus impacts human cells by initiating a series of interactions once it enters the blood system. It hijacks the host's cellular machinery to replicate and generate viral particles. It triggers immune responses leading to production of antibodies such as anti-Dengue antibodies. The virus does not operate alone but within a complex involving the host immune response influencing cell signaling pathways.
Pathways
Dengue Virus is integrated into the type I interferon signaling pathway and the TLR3 signaling pathway. These pathways trigger antiviral responses that attempt to limit viral replication. The virus interacts with host proteins including STAT1 and IRF3 which play roles in these pathways. The virus evades the immune response by modifying these pathways enhancing its survival and replication in the host.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:221 PubMed40102899
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medical virology 96:e29895 PubMed39228306
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of medical virology 93:3362-3373 PubMed33219544
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:11302 PubMed32647259
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 19:1460-1469 PubMed32160714
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular and infection microbiology 9:284 PubMed31456950
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:5816 PubMed28725041
2017
Applications
IF
Species
Unspecified reactive species
Journal of applied microbiology 119:1170-80 PubMed26248692
2015
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 10:e0125690 PubMed25962098
2015
Applications
IF
Species
Unspecified reactive species
PloS one 7:e44835 PubMed22970315
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com